These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16614596)

  • 41. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ
    Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
    Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data.
    Zuckerman JN; Batty AJ; Jones ME
    Travel Med Infect Dis; 2009 Nov; 7(6):329-36. PubMed ID: 19945009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atovaquone/proguanil for plasmodium falciparum malaria.
    Sehdev PS
    Pediatr Infect Dis J; 2002 Aug; 21(8):787-9. PubMed ID: 12192170
    [No Abstract]   [Full Text] [Related]  

  • 45. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
    Høgh B; Clarke PD; Camus D; Nothdurft HD; Overbosch D; Günther M; Joubert I; Kain KC; Shaw D; Roskell NS; Chulay JD;
    Lancet; 2000 Dec; 356(9245):1888-94. PubMed ID: 11130385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options.
    Meltzer E; Rahav G; Schwartz E
    Clin Infect Dis; 2018 May; 66(11):1751-1755. PubMed ID: 29228132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research.
    Schnyder JL; de Jong HK; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP
    Travel Med Infect Dis; 2022; 49():102365. PubMed ID: 35661741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
    Petersen E
    J Travel Med; 2003 May; 10 Suppl 1():S13-5; discussion S21. PubMed ID: 12737755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.
    Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M
    Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J
    Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A man with tropical travel history, fever, and pulmonary infiltrates.
    Wongba W; Ansari MJ; Okoli O; Garapati S; Iroegbu N; Spear JB
    Compr Ther; 2007; 33(1):21-4. PubMed ID: 17984489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.
    Sabchareon A; Attanath P; Phanuaksook P; Chanthavanich P; Poonpanich Y; Mookmanee D; Chongsuphajaisiddhi T; Sadler BM; Hussein Z; Canfield CJ; Hutchinson DB
    Trans R Soc Trop Med Hyg; 1998; 92(2):201-6. PubMed ID: 9764334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
    McGready R; Stepniewska K; Edstein MD; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2003 Oct; 59(7):545-52. PubMed ID: 12955371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
    Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR
    Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
    Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG
    Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives.
    Schnyder JL; de Jong HK; Bache EB; van Hest RM; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP
    Travel Med Infect Dis; 2023; 52():102520. PubMed ID: 36526126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
    Llanos-Cuentas A; Campos P; Clendenes M; Canfield CJ; Hutchinson DB
    Braz J Infect Dis; 2001 Apr; 5(2):67-72. PubMed ID: 11493411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
    Forestier E; Labe A; Raffenot D; Lecomte C; Rogeaux O
    Med Mal Infect; 2011 Jan; 41(1):41-3. PubMed ID: 20800398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.